PWE Stock Overview
PW Medtech Group Limited, an investment holding company, operates as a medical device company in the People’s Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
PW Medtech Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.098 |
| 52 Week High | HK$0.13 |
| 52 Week Low | HK$0.042 |
| Beta | 0.76 |
| 1 Month Change | 6.52% |
| 3 Month Change | 39.01% |
| 1 Year Change | 24.05% |
| 3 Year Change | 55.56% |
| 5 Year Change | -25.76% |
| Change since IPO | -69.66% |
Recent News & Updates
Recent updates
Shareholder Returns
| PWE | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 1.0% | -1.7% | -1.0% |
| 1Y | 24.1% | -11.2% | 2.2% |
Return vs Industry: PWE exceeded the German Medical Equipment industry which returned -11.2% over the past year.
Return vs Market: PWE exceeded the German Market which returned 2.2% over the past year.
Price Volatility
| PWE volatility | |
|---|---|
| PWE Average Weekly Movement | 19.5% |
| Medical Equipment Industry Average Movement | 4.5% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.3% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: PWE's share price has been volatile over the past 3 months.
Volatility Over Time: PWE's weekly volatility has increased from 13% to 20% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 1,244 | Yue'e Zhang | www.pwmedtech.com |
PW Medtech Group Limited, an investment holding company, operates as a medical device company in the People’s Republic of China. The company manufactures and sells infusion sets, such as non-PVC-based infusion sets, precision filter infusion sets, light resistant infusion sets, intravenous cannula products, and insulin needles and pens; hemodialysis and blood purification medical devices, high flux hemodialyzers, low flux hemodialyzers, hemodiafilters, and hemoperfutors; and animal-derived regenerative medical biomaterials and human tissue repair alternative products. The company was formerly known as Pyholding Limited.
PW Medtech Group Limited Fundamentals Summary
| PWE fundamental statistics | |
|---|---|
| Market cap | €184.12m |
| Earnings (TTM) | €19.72m |
| Revenue (TTM) | €86.89m |
9.3x
P/E Ratio2.1x
P/S RatioIs PWE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PWE income statement (TTM) | |
|---|---|
| Revenue | CN¥675.08m |
| Cost of Revenue | CN¥294.19m |
| Gross Profit | CN¥380.90m |
| Other Expenses | CN¥227.71m |
| Earnings | CN¥153.18m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.098 |
| Gross Margin | 56.42% |
| Net Profit Margin | 22.69% |
| Debt/Equity Ratio | 0% |
How did PWE perform over the long term?
See historical performance and comparisonDividends
10.0%
Current Dividend Yield91%
Payout RatioDoes PWE pay a reliable dividends?
See PWE dividend history and benchmarks| PW Medtech Group dividend dates | |
|---|---|
| Ex Dividend Date | Jul 04 2024 |
| Dividend Pay Date | Jul 26 2024 |
| Days until Ex dividend | 58 days |
| Days until Dividend pay date | 80 days |
Does PWE pay a reliable dividends?
See PWE dividend history and benchmarks